Virios Therapeutics (VIRI) Tops Q3 EPS by 18c
Tweet
Share
E-mailGet Alerts VIRI Hot Sheet
Join SI Premium – FREE
Virios Therapeutics (NASDAQ: VIRI) reported Q3 EPS of ($0.28), $0.18 better than the analyst estimate of ($0.46).
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- CrowdStrike (CRWD) PT Lowered to $227 at Scotiabank
- Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
